AstraZeneca vaccine will be tested on children

About 300 volunteers will participate in the study, which is expected to begin late February, broadcast the BBC.

AstraZenecas vaccine is being used in Britain and European Union countries, along with Pfizer vaccines/ BioNTech. The World Health Organization has also recommended that AstraZenecia vaccine be used. This vaccine is said to have 63.9 percent efficiency with COVID-19.

In the study to be carried out, 240 children will receive the AstraZeneca vaccine, while others will take it for meningitis control.

In preliminary studies conducted by Oxford and AstraZeneca, children were not involved.

Andrew. Pollard, professor of infection and pediatric immunity, simultaneously chief inspector of the Oxford vaccine clinical trials, has stressed that most children are not affected by COVID-19 and that those affected are unlikely to have serious diseases.

But he said it is important to understand the security and immune responses from vaccines in children and teenagers, since children, according to him, can also benefit from anti - coronary vaccine.

The AstraZenza vaccine is currently approved for use in persons over 18.

The dose of this vaccine is expected to take away Kosovo, from WHO's COVAX programme, aimed at distributing vaccines to poor countries.

From COVAX, Kosovo is expected to receive 100,800 doses of AstraZenecas vaccine. First doses, according to O office The BSH in Pristina is expected to arrive in half February or third week of February.